112 related articles for article (PubMed ID: 24044571)
1. Biomarkers in childhood non-Hodgkin's lymphomas.
Dokmanovic L
Biomark Med; 2013 Oct; 7(5):791-801. PubMed ID: 24044571
[TBL] [Abstract][Full Text] [Related]
2. Classification of non-Hodgkin's lymphomas in children.
Perkins SL; Segal GH; Kjeldsberg CR
Semin Diagn Pathol; 1995 Nov; 12(4):303-13. PubMed ID: 8578025
[TBL] [Abstract][Full Text] [Related]
3. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
5. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E
Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
7. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
8. Childhood non-Hodgkin's lymphomas: clinical and therapeutic aspects.
Vannier JP
Biomed Pharmacother; 1988; 42(4):263-9. PubMed ID: 3191204
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphomas presenting as cutaneous lesions.
Yaqoob N; Noorali S; Nasir MI; Pervez S
J Coll Physicians Surg Pak; 2003 Jan; 13(1):29-32. PubMed ID: 12685972
[TBL] [Abstract][Full Text] [Related]
10. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
11. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
12. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
Pituch-Noworolska A; Miezyński W
Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
14. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
Bień E; Balcerska A; Ciesielski D
Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies.
Almasri NM; Habashneh MA; Khalidi HS
Saudi Med J; 2004 May; 25(5):609-14. PubMed ID: 15138528
[TBL] [Abstract][Full Text] [Related]
16. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
17. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases?
Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S
J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
19. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
20. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.
Naresh KN; Advani S; Adde M; Aziz Z; Banavali S; Bhatia K; Belgaumi A; Ezzat A; Khaled H; Mokhtar N; Norton A; Rohatiner A; Sagar TG; Taciyliz N; Temmim L; Venkatesh C; Yan Tang J; Magrath I
Blood Cells Mol Dis; 2004; 33(3):330-7. PubMed ID: 15528153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
